JoVE Journal
Medicine
Medicine
A subscription to JoVE is required to view this content.
Modellering Kjemoterapi Resistant Leukemi
The JoVE video player is compatible with HTML5 and Adobe Flash. Older browsers that do not support HTML5 and the H.264 video codec will still use a Flash-based video player. We recommend downloading the newest version of Flash here, but we support all versions 10 and above.
If that doesn't help, please let us know.
Unable to load video. Please check your Internet connection and reload this page. If the problem continues, please let us know and we'll try to help.
An unexpected error occurred. Please check your Internet connection and reload this page. If the problem continues, please let us know and we'll try to help.
Click here for the English version
Article
DOI:
10.3791/53645-v
•
08:41 min
•
February 9th, 2016
Modellering Kjemoterapi Resistant Leukemi
February 9th, 2016
•
William L. Slone*1, Blake S. Moses*1, Rebecca Evans1, Debbie Piktel1, Karen H. Martin1,2, William Petros1, Michael Craig1, Laura F. Gibson1,3
1Alexander B. Osborn Hematopoietic Malignancy and Transplantation Program of the Mary Babb Randolph Cancer Center, Robert C. Byrd Health Sciences Center, West Virginia University School of Medicine, 2Department of Neurobiology and Anatomy, Robert C. Byrd Health Sciences Center, West Virginia University School of Medicine, 3Department of Microbiology, Immunology and Cell Biology, Robert C. Byrd Health Sciences Center, West Virginia University School of Medicine
* These authors contributed equally